Reproduction rates after cancer treatment: experience from the norwegian radium hospital

Journal of Clinical Oncology

Volumn 27, Issue 3, 2009, Pages 334-343

  Cvancarova, Milada ^a   Samuelsen, Sven Ove ^a   Magelssen, Henriette ^a   Fosså, Sophie Dorothea ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PREDNISONE; PROCARBAZINE; TAMOXIFEN; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CANCER SURVIVOR; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FERTILITY; HAZARD RATIO; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; OVARY CANCER; PARENTHOOD; PRIORITY JOURNAL; REPRODUCTION; SEX DIFFERENCE; TESTIS CANCER; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGE FACTORS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; REPRODUCTION; SAFETY MANAGEMENT; SEX FACTORS;

EID: 58749102750     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.3130     Document Type: Article

References (58)

1. Verdecchia A, Francisci S, Brenner H, et al: Recent cancer survival in Europe: A 2000-02 period analysis of EUROCARE-4 data. The Lancet Oncology 8:784-796, 2007
2. Dubey P, Wilson G, Mathur KK, et al: Recovery of sperm production following radiation therapy for Hodgkin's disease after induction chemotherapy with mitoxantrone, vincristine, vinblastine, and prednisone (NOVP). Int J Radiat Oncol Biol Phys 46:609-617, 2000
3. Franchi-Rezgui P, Rousselot P, Espié M, et al: Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lym-phomas. Hematol J 4:116-120, 2003
4. Behringer K, Breuer K, Reineke T, et al: Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: A report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol 23:7555-7564, 2005
5. Hodgson DC, Pintilie M, Gitterman L, et al: Fertility among female Hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy. Hematol Oncol 25:11-15, 2007
6. van der Kaaij MA, Heutte N, Le Stang N, et al: Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lym-phoma Group and the Groupe d'Etude des Lym-phomes de l'Adulte. J Clin Oncol 25:2825-2832, 2007
7. Kiserud CE, Fosså A, Holte H, et al: Post-treatment parenthood in Hodgkin's lymphoma survivors. Br J Cancer 96:1442-1449, 2007
8. Huddart RA, Norman A, Moynihan C, et al: Fertility, gonadal and sexual function in survivors of testicular cancer. Br J Cancer 93:200-207, 2005
9. Brydøy M, Fosså SD, Klepp O, et al: Paternity following treatment for testicular cancer. J Natl Cancer Inst 97:1580-1588, 2005
10. Del Mastro L, Catzeddu T, Venturini M: Infertility and pregnancy after breast cancer: Current knowledge and future perspectives. Cancer Treat Rev 32:417-422, 2006
11. Gershenson DM, Miller AM, Champion VL, et al: Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: A Gynecologic Oncology Group Study. J Clin Oncol 25:2792-2797, 2007
12. Boss EA, van Golde RJ, Beerendonk CC, et al: Pregnancy after radical trachelectomy: A real option? Gynecol Oncol 99:152-156, 2005
13. Sjøborg KD, Vistad I, Myhr SS, et al: Pregnancy outcome after cervical cone excision: A case-control study. Acta Obstet Gynecol Scand 86:423-428, 2007
14. Swerdlow AJ, Jacobs PA, Marks A, et al: Fertility, reproductive outcomes, and health of offspring, of patients treated for Hodgkin's disease: An investigation including chromosome examinations. Br J Cancer 74:291-296, 1996
15. Tawn EJ, Whitehouse CA, Winther JF, et al: Chromosome analysis in childhood cancer survivors and their offspring: No evidence for radiotherapy-induced persistent genomic instability. Mutat Res 583:198-206, 2005
16. Magelssen H, Melve KK, Skjaerven R, et al: Parenthood probability and pregnancy outcome in patients with a cancer diagnosis during adolescence and young adulthood. Hum Reprod 23:178-186, 2008
17. Fossa SD, Magelssen H, Melve K, et al: Parenthood in survivors after adulthood cancer and perinatal helath in their offspring: A preliminary report. J Natl Cancer Inst Monogr 34:77-82, 2005
18. Syse A, Kravdal Ø, Tretli S: Parenthod after cancer: A population based study. Psycho-Oncology 16:920-927, 2007
19. Therneau TM, Grambsch PM: Testing proportional hazards, in Dietz K, Gail M, Krisckeberg K, etal (eds): Modeling Survival Data: Extending the Cox Model (ed 2). New York, NY, Springer, 2001, pp 127-142
20. Kolstad P: Clinical Gynecologic Oncology: The Norwegian Experience. Oxford, United Kingdom, Oxford University Press, 1986, pp 1-247
21. Rampone JF, Klem V, Kolstad P: Combined treatment of stage 1b carcinoma of the cervix. Obstet Gynecol 41:163-167, 1973
22. Vergote IB, Abeler VM, Kj0rstad KE, et al: Management of malignant ovarian immature tera-toma. Cancer 66:882-886, 1990
23. Gershenson DM, Morris M, Cangir A, et al: Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol 8:715-720, 1990
24. Hoff Wanderås E, Fosså SD, Tretli S, et al: Toxicity in long-term survivors after adriamycin containing chemotherapy of malignant germ cell tumors. Int J Oncol 4:681-688, 1994
25. Marth C, Tropé C, Vergote IB, et al: Ten-year results of a randomised trial comparing cisplatin with cisplatin and cyclophosphamide in advanced, suboptimally debulked ovarian cancer. Eur J Cancer 34:1175-1180, 1998
26. Trope C, Kaern J: Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature. J Clin Oncol 25:2909-2920, 2007
27. Høst H, Brennhovd IO, Loeb M: Postoperative radiotherapy in breast cancer: Long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 12:727-732, 1986
28. Norwegian Cancer Society: Cancer mammae: Primary treatment (ed 1). Oslo, Norway, Norwegian Surgical Association, 1981
29. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339:1-15, 1992
30. Hoppe RT, Coleman CN, Cox RS, et al: The management of stage I-II Hodgkin's disease with irradiation alone or combined modality therapy: The Stanford experience. Blood 59:455-465, 1982
31. Abrahamsen AF, Høst H: Mantle field irradiation for stages IA and IIA Hodgkin's disease. Scand J Haematol 26:306-310, 1981
32. Bonadonna G, Santoro A: ABVD chemotherapy in the treatment of Hodgkin's disease. Cancer Treat Rev 9:21-35, 1982
33. Huguley CM Jr, Durant JR, Moores RR, et al: A comparison of nitrogen mustard, vinsristine, pro-carbazine, and prednisone (MOPP) vs nitrogen mustard in advanced Hodgkin's disease. Cancer 36: 1227-1240, 1975
34. Mendenhall NP: The role of radiation in the management of Hodgin's disease: An update. Cancer Invest 17:47-55, 1999
35. Holte H, Mella O, Wist E, et al: ChIVPP is as effective as alternating ChIVPP/ABOD in advanced stage Hodgkin's disease. Acta Oncol 35:73-80, 1996
36. Blystad AK, Holte H, Kvaløy S, et al: High-dose therapy in patients with Hodgkin's disease: The use of selected CD34(+) cells is as safe as unmanipu-lated peripheral blood progenitor cells. Bone Marrow Transplant 28:849-857, 2001
37. Fosså SD, Aass N, Kaalhus O: Radiotherapy for testicular semonoma stage I: Treatment results and long-term post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys 16:383-388, 1989
38. Jacobsen KD, Olsen DR, Fosså K, et al: External beam abdominal radiotherapy in patients with seminoma stage I: Field type, testicular dose, and spermatogenesis. Int J Radiat Oncol Biol Phys 38: 95-102, 1997
39. Fosså SD, Borge L, Aass N, et al: The treatment of advanced metastatic seminoma: Experience in 55 cases. J Clin Oncol 5:1071-1077, 1987
40. Fosså SD, Stenvwig AE, Lien HH, et al: Non-seminomatous testicular cancer clinical stage I: Prediction of outcome by histopathological parameters: A multivariate analysis. Oncology 46:297-300, 1989
41. Fosså SD, Klepp O, Ous S, et al: Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage I. Eur Urol 10:17-23, 1984
42. Fosså SD, Jacobsen Ab, Aass N, et al: How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources? Br J Cancer 70: 1156-1160, 1994
43. Dearnaley DP, Fosså SD, Kaye SB, et al: Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: A prospective trial (MRC TE17). Br J Cancer 92:2107-2113, 2005
44. Horwich A, Shipley J, Huddart R: Testicular germ-cell cancer. Lancet 367:754-765, 2006
45. Jacobsen KD, Ous S, Waehre H, et al: Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection. Br J Cancer 80:249-255, 1999
46. Fosså SD, Jacobsen AB, Aass N, et al: How safe is surveillance in patients with histopathologi-cally low-risk non-seminomatous testicular cancer in a geographically extended country with limited com-puterized tomographic resources? Current Opinion in Urology 9:425-429, 1999
47. Fosså SD, Horwich A, Russel JM, et al: Optimal planning target volume for stage I testicular seminoma: A medical Research Council randomized trial: Medical Research Council Testicular Tumor Working Group. J Clin Oncol 17:3004-3005, 1999
48. Abrahamsen AF, Hannisdal E, Nome O, et al: Clinical stage I and II Hodgkin's disease: Long-term results of therapy without laparotomy: Experience at one institution. Ann Oncol 7:115-117, 1996
49. Schover LR: Psychosocial aspects of infertility and decisions about reproduction in young cancer survivors: A review. Med Pediatr Oncol 33:53-59, 1999
50. Syse A, Tretli S, Kravdal Ø: Cancer's impact on employment and earning: A population-based study from Norway. Journal of Cancer Survivorship (in press)
51. Møller H, Skakkebaek NE: Risk of testicular cancer in subfertile men: Case-control study. BMJ 318:559-562, 1999
52. Efstathiou E, Logothetis CJ: Review of late complications of treatment and late relapse in tes-ticular cancer. J Natl Compr Canc Netw 4:1059-1070, 2006
53. Doria-Rose VP, Biggs ML, Weiss NS: Subfer-tility and the risk of testicular germ cells tumors (United States). Cancer Causes Control 16:651-656, 2005
54. Oosterhuis JW, Looijenga LH: The biology of human germ cell tumours: Retrospective speculations and new prospectives. Eur Urol 23:245-250, 1993
55. Bahadur G, Ozturk O, Muneer A, et al: Semen quality before and after gonadotoxic treatment. Hum Reprod 20:774-781, 2005
56. Lampe H, Horwich A, Norman A, etal: Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol 15:239-245, 1997
57. Schover LR, Brey K, Lichlin A, et al: Knowledge and experience regarding cancer, infertility, and sperm banking in young male survivors. J Clin Oncol 20:1880-1889, 2002
58. Magelssen H, Haugen TB, von During V, et al: Twenty years experience with semen cryopreserva-tion in testicular cancer patients: Who needs it? Eur Urol 48:779-785, 2005